Here are four things to know about the rating action and MSMC’s outlook.
1. The rating action affects roughly $290 million of debt.
2. The affirmation was supported by a number of factors, including MSMC’s ability to generate healthy operating margins, strengthen balance sheet measures and increase volume capture, through its expanded ambulatory footprint and growth in higher-end clinical areas such as cardiac services, according to Moody’s.
3. MSMC also faces challenges, which were considered for the rating action, such as a competitive market, increased capital spend that carries construction risk, ongoing Medicare pressures and Medicaid funding pressures in Florida and still above average leverage measures.
4. MSMC’s outlook is stable, which reflects Moody’s expectations “that MSMC will sustain operating performance at levels consistent with FY 2014 and maintain current levels of unrestricted investments and issue no incremental debt.”
More articles on healthcare finance:
King v. Burwell decision would cause most Americans to switch healthcare providers
Moody’s affirms Children’s Healthcare of Atlanta’s bond rating: 4 things to know
Considerations for REIT or MLP formation by healthcare not-for-profit organizations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
